BioSpace News Archive

Omada Health, a chronic care integrated healthcare provider, announced its $192 million Series E funding round led by Fidelity Management & Research Company with participation from aMoon, existing investorsPerceptive Advisors, Wellington Management, Civilization Ventures, and others.

PacBio welcomes Michael Eberle, Ph.D., as Vice President of Computational Biology.

Propanc Biopharma, Inc., a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced that the joint research partnership with the Universities of Jaén and Granada, Spain, is entering its thirteenth year since their collaboration began in 2009.

Parexel, a leading global clinical research organization (CRO), and n-Lorem, a nonprofit foundation, today announced a new partnership in support of n-Lorem’s effort to discover and provide experimental antisense oligonucleotide (ASO) medicines to nano-rare disease patients (1 to 30 patients worldwide) for free, for life.

Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today the publication of a large real-world clinical utility study in the peer-reviewed journal, Urology Practice, a peer-reviewed journal of the American Urological Association.

Veristat, a scientific-minded global clinical research organization (CRO), announced the appointment of Joe Scott to the position of Chief Financial Officer

According to the World Health Organization, the most common type of cancer incident in the US is breast cancer, with approximately 234,087 breast cancer cases and 41,904 deaths in 2018.

Rising prevalence of chronic and acute diseases worldwide and rapid adoption of clinical decision support systems in healthcare settings are among the key factors driving market revenue growth.

NGMedical, a German medical device manufacturer exclusively focused on creating innovative technologies for spinal applications announces the first USA implantation of its purely additively manufactured titanium BEE® PLIF.

Medical imaging reagents have been playing a crucial role in facilitating medical imaging process for patients.